Clinical Trials Arena on MSN
ESMO26: Key data breathing new life into the lung cancer field
Clinical Trials Arena brings you the lung cancer highlights from ESMO 2026, with readouts from key players MSD, AstraZeneca, ...
Gilead Sciences reported its strongest base business growth in more than a decade, with third-quarter 2026 sales of $8.2 billion excluding Veklury, ...
Kyverna Therapeutics advances Miv-cel for autoimmune diseases, but valuation, launch, and funding risks remain. Click here to ...
The Chosun Ilbo on MSN
Kyobo Life Insurance marks 42 years supporting youth sports, education
Kyobo Life Insurance, founded in 1958 with the founding ideals of "National Education Promotion" and "Ethnic Capital ...
Students in the nation’s capital posted gains in math and reading for the fourth straight year, according to the results of ...
Prison air is “fetid” and “suffocating,” Mahvash Sabet writes in her new memoir, Open Wide the Doors, offering a rare account ...
Well, my son's middle school entrance exams are over. He had a deviation score of less than 50 in 4th grade. He wouldn't do his homework. My son, who only ever ran around the house, fought hard in the ...
"Lately, I can't finish my cram school homework.""My test scores aren't stable.""Will it be okay to enter 6th grade like this ...
Direct-from-Source Access Deepens Longitudinal Clinical Records, Strengthening OneMedNet's Position as a Preferred Source of Regulatory-Grade, AI-Ready Real-World DataMINNEAPOLIS, Oct. 15, 2026 (GLOBE ...
Research points to trust as the real barrier to scaling agentic AI, with 58% saying the industry still lacks clear standards for responsible AI TORONTO and NE ...
Researchers embedded implementation science principles into an ongoing infant physical therapy trial to make early neuromotor ...
The changes have drawn criticism from educators, parents, and community members over how evolution and human-caused climate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results